Stephanie Seidman

Specialize in strategic counseling and patent prosecution throughout the world for early stage/emerging companies in the biopharma area.

Stephanie Seidman has decades of experience providing strategic counsel on the development and commercialization of patent portfolios for the biopharma industry. She has drafted and prosecuted hundreds of pharmaceutical, biotechnical, and chemical patents, notably patent portfolios involving complex technologies. Her expertise includes molecular biology, including viral vectors and therapeutic viruses, therapeutic proteins, small molecules, chemical processes, immunology, screening, stem cells, immunotherapies, and diagnostics. Her work includes patent prosecution, focusing on early-stage patenting strategies; freedom-to-operate analyses; non-infringement and validity analyses; and IP due diligence work in financing and acquisitions.

Stephanie is recognized for her representation of emerging and developing companies, including private and public companies in the biotech and pharmaceutical industries. Her prior experience includes three decades in private practice and several years as a patent examiner for the U.S. Patent and Trademark Office. She also was a postdoctoral staff fellow at the National Institutes of Health.

American Bar Association; American Chemical Society; Women in Bio

Catholic University of America Columbus School of Law, 1985, JD; Indiana University, (molecular biology/biochemistry), Ph.D.; Indiana University, (chemical physics), MS; William Smith College, (chemistry, physics), BS.